Union Korea Pharm Co., Ltd. (KOSDAQ: 080720)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,725.00
-310.00 (-10.21%)
Oct 11, 2024, 9:00 AM KST

Union Korea Pharm Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Operating Revenue
64,22363,16961,29348,30450,37951,264
Upgrade
Other Revenue
-0-0---0
Upgrade
Revenue
64,22363,16961,29348,30450,37951,264
Upgrade
Revenue Growth (YoY)
3.42%3.06%26.89%-4.12%-1.73%-6.22%
Upgrade
Cost of Revenue
40,91442,38837,37733,15431,11327,076
Upgrade
Gross Profit
23,30920,78123,91715,15019,26724,189
Upgrade
Selling, General & Admin
26,52524,67522,14723,98724,07716,285
Upgrade
Research & Development
823.36833.33922.152,451988.78338.61
Upgrade
Other Operating Expenses
254.37244.29294.22196.45190.14240.5
Upgrade
Operating Expenses
40,27135,46322,64625,76430,09823,397
Upgrade
Operating Income
-16,962-14,6821,271-10,615-10,832791.3
Upgrade
Interest Expense
-4,262-4,112-2,843-2,229-667.41-636.29
Upgrade
Interest & Investment Income
77.89105.4347.6146.6440.0654.86
Upgrade
Earnings From Equity Investments
-26.96-19.46-5.47-9.49--
Upgrade
Currency Exchange Gain (Loss)
56.889.98-55.1496.43-108.6620.42
Upgrade
Other Non Operating Income (Expenses)
1,6651,6952,528-1,628-210.37317.63
Upgrade
EBT Excluding Unusual Items
-19,451-17,004943.54-14,338-11,778547.93
Upgrade
Gain (Loss) on Sale of Investments
-----16.89
Upgrade
Gain (Loss) on Sale of Assets
126.46129.04-7.54-306.3121.44
Upgrade
Asset Writedown
----146.73--
Upgrade
Other Unusual Items
298.772,471----
Upgrade
Pretax Income
-19,026-14,404943.54-14,477-12,084586.26
Upgrade
Income Tax Expense
3,7513,7531,876-3,367-2,762175.1
Upgrade
Net Income
-22,777-18,156-932.02-11,109-9,322411.16
Upgrade
Net Income to Common
-22,777-18,156-932.02-11,109-9,322411.16
Upgrade
Net Income Growth
------92.95%
Upgrade
Shares Outstanding (Basic)
777876
Upgrade
Shares Outstanding (Diluted)
777876
Upgrade
Shares Change (YoY)
-0.29%-2.14%-5.05%16.95%12.55%17.33%
Upgrade
EPS (Basic)
-3154.77-2514.45-126.31-1429.59-1430.7569.64
Upgrade
EPS (Diluted)
-3154.77-2514.45-126.31-1430.00-1430.7569.53
Upgrade
EPS Growth
------94.00%
Upgrade
Free Cash Flow
5,206-901.15-8,429-5,254-10,039-19,272
Upgrade
Free Cash Flow Per Share
721.10-124.80-1142.33-676.09-1510.90-3264.33
Upgrade
Gross Margin
36.29%32.90%39.02%31.36%38.24%47.18%
Upgrade
Operating Margin
-26.41%-23.24%2.07%-21.97%-21.50%1.54%
Upgrade
Profit Margin
-35.47%-28.74%-1.52%-23.00%-18.50%0.80%
Upgrade
Free Cash Flow Margin
8.11%-1.43%-13.75%-10.88%-19.93%-37.59%
Upgrade
EBITDA
-13,373-10,7925,266-6,389-7,0843,266
Upgrade
EBITDA Margin
-20.82%-17.08%8.59%-13.23%-14.06%6.37%
Upgrade
D&A For EBITDA
3,5893,8903,9944,2263,7472,474
Upgrade
EBIT
-16,962-14,6821,271-10,615-10,832791.3
Upgrade
EBIT Margin
-26.41%-23.24%2.07%-21.97%-21.50%1.54%
Upgrade
Effective Tax Rate
--198.78%--29.87%
Upgrade
Advertising Expenses
-1,984865.841,0901,6183,300
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.